ziv-aflibercept
ziv-aflibercept is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including ZALTRAP. Available dosage form: solution, concentrate.
Drug Details
- Generic Name
- ziv-aflibercept
- Brand Names
- ZALTRAP
- Application Number
- BLA125418
- Sponsor
- sanofi-aventis U.S. LLC
- NDC Codes
- 2
- Dosage Forms
- SOLUTION, CONCENTRATE
- Routes
- INTRAVENOUS
- Active Ingredients
- AFLIBERCEPT
Indications and Usage
1 INDICATIONS AND USAGE ZALTRAP, in combination with fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen. ZALTRAP, a vascular endothelial growth factor inhibitor, in combination with fluorouracil, leucovorin, irinotecan (FOLFIRI), is indicated for the treatment of patients with metastatic colorectal cancer that is resistant to or has progressed following an oxaliplatin-containing regimen. ( 1 )